HOME - Companies - Products
 
 
12 January 2022

BIOLASE and EdgeEndo announce FDA 510(k) clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists

The EdgePRO system offers a more effective, innovative cleaning and disinfection technology for the endodontic community


BIOLASE, the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced today the FDA 510(k) clearance of the EdgePRO system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures. The new laser-assisted microfluidic irrigation device offers an advanced solution to current cleaning and disinfection techniques without disrupting procedure workflow or adding substantial cost on a per-procedure basis.

The EdgePRO Laser-Assisted Microfluidic Irrigation device is built upon BIOLASE's patented and proven platform, Er,Cr:YSGG 2780 nm wavelength laser technology, that has been shown to provide outstanding debridement1, cleaning, and disinfection by removing infected tissue, biofilms10,11, smear layer5-9, and killing up to 99% of bacteria commonly found in the root canal2-4, through the combination of advanced laser light-sound technology with traditional irrigation solutions.

BIOLASE will manufacture the EdgePRO system, consumable procedure tips, and accompanying accessories for EdgeEndo, which will capitalize on their unique ability to commercialize high-quality, innovative products within the endodontic specialty. EdgeEndo will commence selling the EdgePRO system and related products immediately within the U.S. and will work closely with BIOLASE to ensure the needs of the endodontic community are satisfied with this enabling technology platform. 

"This clearance enables endodontists to access state-of-the-art technology that has the potential to improve clinical outcomes and patient experiences. We remain committed to offering products and solutions that may enhance specialist skills in providing the highest quality of care for their patients while producing streamlined efficiencies for practices in a cost-effective manner," said Dr. Charles Goodis, DDS, EdgeEndo founder, and CEO. "We are proud to partner with BIOLASE, in our combined effort to service and support the specialty with innovative and effective technologies that may elevate the quality of dental care."

"We're very pleased to complete our first OEM project, receive FDA 510(k) clearance, and deliver EdgePro units to EdgeEndo in only 12 months," adds BIOLASE President and CEO John Beaver. "This achievement is an excellent example of cross-functional teamwork between our two market-leading companies, and we look forward to our long and valuable relationship ahead."


Source: www.biolase.com

Related articles

Dental laser company, Biolase, Inc., has begun to offer continuing education opportunities in dental hygiene through its Epic Hygiene Academy. The program is open to any Biolase diode laser users to...


Read more

Inlay and overlay are a good and right choice in case of large carious and restorative defects. The introduction of CAD/CAM system gives the possibilities to...


There is a variety of anesthetics that can obtain the specific requirements of different clinical treatments. For tooth extraction it is necessary to use resources to control suffering and discomfort...


USA     16 January 2022 - 30 November 0001

Explore, Educate, Engage at Yankee Dental Congress 2022

Yankee Dental Congress 2022 runs January 27 – January 29, 2022, at the Boston Convention & Exhibition Center

Yankee, New England’s largest dental meeting, is sponsored by the Massachusetts Dental Society (MDS) in cooperation with the dental societies of Connecticut, Maine, New Hampshire, Rhode Island, and...


The global market for restorative materials and bonding agents is forecast to grow during the decade-long forecast period (2021 to 2031), according to market analysis firm, Transparency Market...


 
 
 
 
 
 

Most popular

 
 

Events

 
 

Copyright © 2022 - All Rights Reserved
ISSN 2767-1178

Top